Case Commentary: Long-Term Fosmanogepix Use in a Transplant Recipient with Disseminated Aspergillosis Caused by Azole-Resistant Aspergillus calidoustus-Reference-Cited by-同舟云学术

Case Commentary: Long-Term Fosmanogepix Use in a Transplant Recipient with Disseminated Aspergillosis Caused by Azole-Resistant Aspergillus calidoustus

Published:2022-03-15 Issue:3 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Kline Ahnika¹,Lionakis Michail S.¹

Affiliation:

1. Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

Abstract

Aspergillus calidoustus is an emerging, azole-resistant, cryptic Aspergillus species in immunosuppressed patients that often features extrapulmonary involvement and carries high mortality. The case presented by J.

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.02368-21

Reference33 articles.

1. Successful treatment of disseminated disease due to highly resistant Aspergillus calidoustus with a novel antifungal therapy

2. Aspergillus calidoustus sp. nov., Causative Agent of Human Infections Previously Assigned to Aspergillus ustus

3. Draft Genome Sequences of Fungus Aspergillus calidoustus

4. Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network

5. Emerging Aspergillus Species Almost Exclusively Associated With Primary Immunodeficiencies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How do I manage refractory invasive pulmonary aspergillosis;Clinical Microbiology and Infection;2024-06

2. Antifungal resistance, combinations and pipeline: oh my!;Drugs in Context;2023-11-09

3. Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now;Expert Review of Anti-infective Therapy;2023-05-01